These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 27990121)

  • 1. Targeting Mechanotransduction at the Transcriptional Level: YAP and BRD4 Are Novel Therapeutic Targets for the Reversal of Liver Fibrosis.
    Zhubanchaliyev A; Temirbekuly A; Kongrtay K; Wanshura LC; Kunz J
    Front Pharmacol; 2016; 7():462. PubMed ID: 27990121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromodomain protein 4 is a key molecular driver of TGFβ1-induced hepatic stellate cell activation.
    Xu F; Lu S; Pan N; Zhao F; Jia X; Wang S; Zhang Y; Zhou Y
    Biochim Biophys Acta Mol Cell Res; 2023 Dec; 1870(8):119569. PubMed ID: 37597774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Hippo pathway effector YAP controls mouse hepatic stellate cell activation.
    Mannaerts I; Leite SB; Verhulst S; Claerhout S; Eysackers N; Thoen LF; Hoorens A; Reynaert H; Halder G; van Grunsven LA
    J Hepatol; 2015 Sep; 63(3):679-88. PubMed ID: 25908270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRD4 is a novel therapeutic target for liver fibrosis.
    Ding N; Hah N; Yu RT; Sherman MH; Benner C; Leblanc M; He M; Liddle C; Downes M; Evans RM
    Proc Natl Acad Sci U S A; 2015 Dec; 112(51):15713-8. PubMed ID: 26644586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRD4 promotes hepatic stellate cells activation and hepatic fibrosis via mediating P300/H3K27ac/PLK1 axis.
    Cheng M; Li JJ; Niu XN; Zhu L; Liu JY; Jia PC; Zhu S; Meng HW; Lv XW; Huang C; Li J
    Biochem Pharmacol; 2023 Apr; 210():115497. PubMed ID: 36907496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD47, a novel YAP target gene, contributes to hepatic stellate cell activation and liver fibrosis induced by high-fat diet.
    Li Y; Dong L; Yin X; Wang X; Zhu X; Zheng P; Tang Y
    Heliyon; 2024 May; 10(10):e31621. PubMed ID: 38831842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting YAP-mediated HSC death susceptibility and senescence for treatment of liver fibrosis.
    Du K; Maeso-Díaz R; Oh SH; Wang E; Chen T; Pan C; Xiang K; Dutta RK; Wang XF; Chi JT; Diehl AM
    Hepatology; 2023 Jun; 77(6):1998-2015. PubMed ID: 36815382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
    Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
    Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromodomain protein 4 mediates the roles of TGFβ1-induced Stat3 signaling in mouse liver fibrogenesis.
    Xu F; Lu S; Jia X; Zhou Y
    Toxicol Lett; 2023 Aug; 385():42-50. PubMed ID: 37634812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule natural plants for reversing liver fibrosis based on modulation of hepatic stellate cells activation: An update.
    Zheng Y; Xie L; Yang D; Luo K; Li X
    Phytomedicine; 2023 May; 113():154721. PubMed ID: 36870824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin suppresses activation of hepatic stellate cells through RORα-mediated inhibition of 5-lipoxygenase.
    Shajari S; Laliena A; Heegsma J; Tuñón MJ; Moshage H; Faber KN
    J Pineal Res; 2015 Oct; 59(3):391-401. PubMed ID: 26308880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of Yap attenuates TAA-induced hepatic fibrosis by interaction with hedgehog signals.
    Zhao Y; Wang H; He T; Ma B; Chen G; Tzeng C
    J Cell Commun Signal; 2023 Dec; 17(4):1335-1354. PubMed ID: 37338798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The m
    Li Y; Kang X; Zhou Z; Pan L; Chen H; Liang X; Chu J; Dong S; Liu C; Yu S; Tu D; Zhang Y; Ge M; Chen W; Xu Y; Zhang Q
    Mol Ther; 2022 Dec; 30(12):3714-3728. PubMed ID: 35923112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation.
    Yan Y; Zeng J; Xing L; Li C
    Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation.
    Huang YH; Kuo HC; Yang YL; Wang FS
    Int J Med Sci; 2019; 16(2):212-220. PubMed ID: 30745801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids Have Opposing Effects on Liver Fibrosis in Hepatic Stellate and Immune Cells.
    Kim KH; Lee JM; Zhou Y; Harpavat S; Moore DD
    Mol Endocrinol; 2016 Aug; 30(8):905-16. PubMed ID: 27355192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis.
    Xiang DM; Sun W; Ning BF; Zhou TF; Li XF; Zhong W; Cheng Z; Xia MY; Wang X; Deng X; Wang W; Li HY; Cui XL; Li SC; Wu B; Xie WF; Wang HY; Ding J
    Gut; 2018 Sep; 67(9):1704-1715. PubMed ID: 28754776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empagliflozin Reduces the Progression of Hepatic Fibrosis in a Mouse Model and Inhibits the Activation of Hepatic Stellate Cells via the Hippo Signalling Pathway.
    Heo YJ; Lee N; Choi SE; Jeon JY; Han SJ; Kim DJ; Kang Y; Lee KW; Kim HJ
    Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer.
    Noguchi S; Saito A; Nagase T
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.